Artemis 2 NASA astronaut Reid Wiseman who commanded the first moon mission in half a century talks to Space.com about the parallels between the two moon efforts. The 55th anniversary of Apollo 8's ...

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...

Gov. Ron DeSantis is set to speak at the Kennedy Space Center on Wednesday afternoon. The Florida Governor will deliver his ...

ChipAgents, the AI-powered development tool for chip design and verification, has achieved state-of-the-art performance on the VerilogEval-v2 benchmark from NVIDIA. This milestone highlights ...

Despite the tightening of catastrophe bond spreads seen through the second-half of 2024 the asset class remains elevated ...

Zions Bancorporation, National Association (NASDAQ:ZION – Free Report) had its price target cut by JPMorgan Chase & Co. from $65.00 to $62.00 in a research note published on Tuesday morning,Benzinga ...

Cryptocurrencies endured a bloodbath over the past day as digital assets plunged following hotter-than-anticipated US labor ...

Actor David Licauco was both chummy and grateful that his show "Pulang Araw" was chosen as the first Filipino series to be ...

American Rare Earths Ltd (ASX:ARR, OTCQB:ARRNF) has been granted a licence enabling it to conduct test mining, trenching and exploratory excavation at the Halleck Creek Rare Earths Project in Wyoming, ...

US FDA grants breakthrough therapy designation to GSK’s B7-H3-targeted ADC, GSK’227 to treat relapsed or refractory osteosarcoma: London, UK Wednesday, January 8, 2025, 10:00 ...

GSK5764227 (HS-20093) is a novel antibody-drug conjugate composed of a fully human anti-B7-H3 monoclonal antibody covalently linked to a topoisomerase inhibitor payload.

Artemis Resources has appointed experienced geologist and mining executive Julian Hanna as managing director to lead the ...